1. Effective Treatment of Helicobacter pyloriInfection Using Supramolecular Antimicrobial Peptide Hydrogels
- Author
-
Gong, Haoning, Wang, Xiaonan, Hu, Xuzhi, Liao, Mingrui, Yuan, Chengqian, Lu, Jian Ren, Gao, Lizeng, and Yan, Xuehai
- Abstract
Helicobacter pylorican cause various gastric conditions including stomach cancer in an acidic environment. Although early H. pyloriinfections can be treated by antibiotics, prolonged antibiotic administrations may lead to the development of antimicrobial resistance, compromising the effectiveness of the treatments. Antimicrobial peptides (AMPs) have been reported to possess unique advantages against antimicrobial-resistant bacteria due to their rapid physical membrane disruptions and anti-inflammation/immunoregulation properties. Herein, we have developed an AMP hydrogel, which can be orally administered for the treatment of H. pyloriinfection. The hydrogel has potent antimicrobial activity against H. pylori, achieving bacterial eradication within minutes of action. Compared with the AMP solution, the hydrogel formulation significantly reduced the cytotoxicity and enhanced proteolytic stability. In vivoexperiments suggested that the hydrogel formed at pH 4 had superior therapeutic effects to those at pH 7 and 10 hydrogels, attributed to its rapid release and bactericidal action within the acidic stomach environment. Compared to conventional antibiotic treatments, the AMP hydrogel had the advantages of fast bacterial killing in the gastric juice and obviated proton pump inhibitors during the treatment. Although both the AMP hydrogel and antibiotics suppressed the expression of pro-inflammatory cytokines, the former uniquely promoted inflammation resolution. These results indicate that the AMP hydrogels with effectiveness and biosafety may be potential candidates for the clinical treatment of H. pyloriinfections.
- Published
- 2024
- Full Text
- View/download PDF